UPC Analytics
ENDE
Overview · Filed: Feb 28, 2025

UPC_CFI_181/2025

A CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY

InfringementMain Infringement ActionDusseldorf LDInfringementWritten Phase
OverviewDecisionsCitationsDocumentsTimeline
Parties

Claimants

  • QIAGEN Sciences, LLC

Respondents

  • bioMérieux SA
  • bioMérieux Deutschland GmbH
Judges
  • Ronny Thomas
  • Jule Schumacher
  • Petri Rinkinen
  • Steen Wadskov-Hansen
Patents
  • EP2726883
CPC codes: Y02A90/10, G01N33/505, G01N33/56966, G01N33/68

Technology area: Medical Devices · Diagnostics

Sector: Measurement & Testing

Outcome
—
Filed: Feb 28, 2025
First decided: —
Language: English
Open on UPC Registry